Lawmakers, advocates champion MDMA as a'game-changer' in PTSD treatment

Advocates and lawmakers across the politicalspectrum are optimistic about its chances forapproval and pushing for a speedy rollout of so-called"MDMA-assisted therapy," which they say could finallyreduce the more than 6,000 veterans who die by suicide each year.

Correction: Lykos, whose primary shareholder is theMultidisciplinary Association for Psychedelic Studies,conducted the Phase 3 trial.